Various PK parameters after oral administration of Niclosamide and ASD-5 in SD rats.
Parameter . | Unit . | Niclosamide . | ASD-5 . | Fold-increase (ASD-5 vs. Niclosamide) . |
---|---|---|---|---|
Tmax | h | 0.83 ± 0.29 | 0.417 ± 0.144 | NA |
Cmax | ng/ml | 279 ± 142 | 909 ± 150 | 3.26 |
AUClast | h*ng/ml | 1005 ± 463 | 2334 ± 321 | 2.32 |
AUCInf | h*ng/ml | 1024 ± 455 | 2387 ± 243 | 2.33 |
Parameter . | Unit . | Niclosamide . | ASD-5 . | Fold-increase (ASD-5 vs. Niclosamide) . |
---|---|---|---|---|
Tmax | h | 0.83 ± 0.29 | 0.417 ± 0.144 | NA |
Cmax | ng/ml | 279 ± 142 | 909 ± 150 | 3.26 |
AUClast | h*ng/ml | 1005 ± 463 | 2334 ± 321 | 2.32 |
AUCInf | h*ng/ml | 1024 ± 455 | 2387 ± 243 | 2.33 |
Tmax, time to reach maximum plasma concentration; Cmax, maximum plasma concentration; AUC, area under the curve.
Various PK parameters after oral administration of Niclosamide and ASD-5 in SD rats.
Parameter . | Unit . | Niclosamide . | ASD-5 . | Fold-increase (ASD-5 vs. Niclosamide) . |
---|---|---|---|---|
Tmax | h | 0.83 ± 0.29 | 0.417 ± 0.144 | NA |
Cmax | ng/ml | 279 ± 142 | 909 ± 150 | 3.26 |
AUClast | h*ng/ml | 1005 ± 463 | 2334 ± 321 | 2.32 |
AUCInf | h*ng/ml | 1024 ± 455 | 2387 ± 243 | 2.33 |
Parameter . | Unit . | Niclosamide . | ASD-5 . | Fold-increase (ASD-5 vs. Niclosamide) . |
---|---|---|---|---|
Tmax | h | 0.83 ± 0.29 | 0.417 ± 0.144 | NA |
Cmax | ng/ml | 279 ± 142 | 909 ± 150 | 3.26 |
AUClast | h*ng/ml | 1005 ± 463 | 2334 ± 321 | 2.32 |
AUCInf | h*ng/ml | 1024 ± 455 | 2387 ± 243 | 2.33 |
Tmax, time to reach maximum plasma concentration; Cmax, maximum plasma concentration; AUC, area under the curve.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.